D3 Pharma

About D3 Pharma

D3 Pharma is a specialty pharmaceutical company established in 2009 with the principle objective of providing European and worldwide access to clinically effective, high-strength vitamin D products for the treatment of vitamin D deficiency, insufficiency and associated conditions. 

D3 Pharma, and it's partner Auden Mckenzie Limited, successfully developed and gained UK Marketing Authorisations for the first range of high-strength vitamin D3 products, which are marketed under the trade name Plenachol®.

D3 Pharma continues to broaden its vitamin D3 product range to address areas of high unmet need, particularly for the paediatric and geriatric population worldwide.